173 related articles for article (PubMed ID: 7871089)
1. Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.
Willner P; Lappas S; Cheeta S; Muscat R
Psychopharmacology (Berl); 1994 Aug; 115(4):454-62. PubMed ID: 7871089
[TBL] [Abstract][Full Text] [Related]
2. Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia.
Papp M; Willner P; Muscat R
Psychopharmacology (Berl); 1993; 110(1-2):159-64. PubMed ID: 7870877
[TBL] [Abstract][Full Text] [Related]
3. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline.
Muscat R; Papp M; Willner P
Psychopharmacology (Berl); 1992; 109(4):433-8. PubMed ID: 1365858
[TBL] [Abstract][Full Text] [Related]
4. Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant.
D'Aquila P; Monleon S; Borsini F; Brain P; Willner P
Eur J Pharmacol; 1997 Dec; 340(2-3):121-32. PubMed ID: 9537806
[TBL] [Abstract][Full Text] [Related]
5. Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer.
Cheeta S; Broekkamp C; Willner P
Psychopharmacology (Berl); 1994 Dec; 116(4):523-8. PubMed ID: 7701058
[TBL] [Abstract][Full Text] [Related]
6. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
[TBL] [Abstract][Full Text] [Related]
7. Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress.
Papp M; Muscat R; Willner P
Psychopharmacology (Berl); 1993; 110(1-2):152-8. PubMed ID: 7870876
[TBL] [Abstract][Full Text] [Related]
8. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress.
Papp M; Willner P; Muscat R
Psychopharmacology (Berl); 1991; 104(2):255-9. PubMed ID: 1876670
[TBL] [Abstract][Full Text] [Related]
9. Behavioural evidence that different neurochemical mechanisms underly stretching-yawning and penile erection induced in male rats by SND 919, a new selective D2 dopamine receptor agonist.
Ferrari F; Pelloni F; Giuliani D
Psychopharmacology (Berl); 1993; 113(2):172-6. PubMed ID: 7855178
[TBL] [Abstract][Full Text] [Related]
10. Potential antidepressant properties of pramipexole detected in locomotor and operant behavioral investigations in mice.
Lehr E
Psychopharmacology (Berl); 2002 Oct; 163(3-4):495-500. PubMed ID: 12373450
[TBL] [Abstract][Full Text] [Related]
11. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
Siuciak JA; Fujiwara RA
Psychopharmacology (Berl); 2004 Sep; 175(2):163-9. PubMed ID: 14985923
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant effects of pramipexole, a novel dopamine receptor agonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
J Neural Transm (Vienna); 1997; 104(4-5):525-33. PubMed ID: 9295183
[TBL] [Abstract][Full Text] [Related]
13. Sucrose intake: increase in non-stressed rats and reduction in chronically stressed rats are both prevented by the gamma-hydroxybutyrate (GHB) analogue, GET73.
Tacchi R; Ferrari A; Loche A; Bertolini A
Pharmacol Res; 2008 Jun; 57(6):464-8. PubMed ID: 18573666
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.
Hall ED; Andrus PK; Oostveen JA; Althaus JS; VonVoigtlander PF
Brain Res; 1996 Dec; 742(1-2):80-8. PubMed ID: 9117424
[TBL] [Abstract][Full Text] [Related]
15. Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors.
Mierau J; Schneider FJ; Ensinger HA; Chio CL; Lajiness ME; Huff RM
Eur J Pharmacol; 1995 Jun; 290(1):29-36. PubMed ID: 7664822
[TBL] [Abstract][Full Text] [Related]
16. Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress.
Pothion S; Bizot JC; Trovero F; Belzung C
Behav Brain Res; 2004 Nov; 155(1):135-46. PubMed ID: 15325787
[TBL] [Abstract][Full Text] [Related]
17. The adrenergic α2 antagonist atipamezole alters the behavioural effects of pramipexole and increases pramipexole concentration in blood plasma.
McCormick PN; Fletcher PJ; Wilson VS; Remington GJ
Life Sci; 2016 Apr; 151():300-304. PubMed ID: 26976325
[TBL] [Abstract][Full Text] [Related]
18. Sexual attraction and copulation in male rats: effects of the dopamine agonist SND 919.
Ferrari F; Giuliani D
Pharmacol Biochem Behav; 1995 Jan; 50(1):29-34. PubMed ID: 7700951
[TBL] [Abstract][Full Text] [Related]
19. Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine.
Papp M; Klimek V; Willner P
Psychopharmacology (Berl); 1994 Aug; 115(4):441-6. PubMed ID: 7871087
[TBL] [Abstract][Full Text] [Related]
20. Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats.
Dardou D; Chassain C; Durif F
Front Neurosci; 2014; 8():437. PubMed ID: 25610366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
